How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
ECLS Oxygenator Market
- By Oxygenator Type: Hollow Fiber Oxygenators, Microporous Membrane Oxygenators, Polymethylpentene (PMP) Oxygenators, Bubble Oxygenators
- By Application: Adult ECMO, Pediatric ECMO, Neonatal ECMO
- By Flow Rate Capacity: Low Flow Oxygenators (<3 L/min), Medium Flow Oxygenators (3-6 L/min), High Flow Oxygenators (>6 L/min)
- By Material Composition: Polypropylene Fiber Oxygenators, Polymethylpentene Fiber Oxygenators, Polyethylene Fiber Oxygenators
- By Circuit Configuration: Integrated Pump-Oxygenator Systems, Standalone Oxygenators
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hollow Fiber Oxygenators leads By Oxygenator Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.170 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the ECLS Oxygenator Market report
A complete, evidence-based study - 12 chapters and 116 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Oxygenator Type 4
Application 3
Flow Rate Capacity 3
Material Composition 3
Circuit Configuration 2
Companies profiled
Medtronic
LivaNova
Terumo Corporation
Getinge (Maquet)
Sorin Group (now part of LivaNova)
Nipro Corporation
Sarns (part of Terumo)
Xenios AG (a Fresenius Medical Care company)
Hemovent GmbH
Carmat
Medos Medizintechnik AG (Getinge)
Senko Medical Instrument Mfg. Co. Ltd.
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →LivaNova
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Getinge (Maquet)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sorin Group (now part of LivaNova)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Sarns (part of Terumo)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Xenios AG (a Fresenius Medical Care company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hemovent GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Carmat
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Medos Medizintechnik AG (Getinge)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Senko Medical Instrument Mfg. Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Fresenius Medical Care
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,724M by 2033 · 7.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hollow Fiber Oxygenators51.5
- Microporous Membrane Oxygenators15.7
- Polymethylpentene (PMP) Oxygenators17.4
- Bubble Oxygenators15.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,481M → $2,405M · 6.2%
Europe$1,032M → $1,646M · 6.0%
Asia Pacific$942.5M → $1,822M · 8.6%
Latin America$583.4M → $1,025M · 7.3%
Middle East and Africa$448.8M → $730.8M · 6.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.982026
6.992027
7.002028
7.012029
7.022030
7.032031
7.052032
7.062033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic17.3
- LivaNova19.4
- Terumo Corporation8.4
- Getinge (Maquet)7.2
- Sorin Group (now part of LivaNova)8.9
- Nipro Corporation11.0
- Others27.8
Segment contribution to growth (%)
Fig. 18 · p.39 →Oxygenator Type27.4%
Application24.2%
Flow Rate Capacity17.9%
Material Composition22.0%
Circuit Configuration8.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe21.6
- Asia Pacific23.9
- Latin America13.4
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 85 | 94 | 79 | 73 | 78 | 87 | 83 |
| LivaNova | 76 | 81 | 93 | 68 | 89 | 91 | 83 |
| Terumo Corporation | 81 | 86 | 68 | 74 | 82 | 66 | 76 |
| Getinge (Maquet) | 70 | 72 | 66 | 71 | 81 | 72 | 72 |
| Sorin Group (now part of LivaNova) | 62 | 67 | 68 | 52 | 58 | 56 | 61 |
| Nipro Corporation | 66 | 48 | 55 | 49 | 59 | 67 | 57 |
| Sarns (part of Terumo) | 44 | 45 | 49 | 42 | 53 | 47 | 47 |
| Xenios AG (a Fresenius Medical Care company) | 47 | 48 | 59 | 38 | 35 | 41 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- LivaNova
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| LivaNova | − | ✓ | ✓ | ✓ | ✓ | ✓ |
| Terumo Corporation | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Getinge (Maquet) | ◐ | ◐ | ◐ | ◐ | ✓ | − |
| Sorin Group (now part of LivaNova) | ◐ | − | ◐ | ◐ | − | − |
| Nipro Corporation | ◐ | ◐ | − | ◐ | − | ✓ |
| Sarns (part of Terumo) | − | ◐ | − | − | ◐ | ◐ |
| Xenios AG (a Fresenius Medical Care company) | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic83
2LivaNova83
3Terumo Corporation76
4Getinge (Maquet)72
5Sorin Group (now part of LivaNova)61
6Nipro Corporation57
7Sarns (part of Terumo)47
8Xenios AG (a Fresenius Medical Care company)45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicLivaNova
Challenger2
Strong scale, closing on the leaders.
Terumo CorporationGetinge (Maquet)
Contender2
Focused players with pockets of strength.
Sorin Group (now part of LivaNova)Nipro Corporation
Niche2
Specialists in a single segment or region.
Sarns (part of Terumo)Xenios AG (a Fresenius Medical Care company)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Oxygenator Type in North America, then scale across ECLS Oxygenator Market — a $110M beachhead inside a $1.75B market.
Beachhead (SOM)$110Mobtainable near-term
Serviceable (SAM)$680Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Hollow Fiber Oxygenators
Best fit — highest urgency & budget in Oxygenator Type.
Economic buyer79 fit
Microporous Membrane Oxygenators
Strong fit — clear ROI and a fast path to value.
End user64 fit
Polymethylpentene (PMP) Oxygenators
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Oxygenator Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Flow Rate Capacity
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Oxygenator Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win ECLS Oxygenator Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation15%
Closed-won6%
$10.5KCAC
$47KLTV
4.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
ECLS Oxygenator Market is a durable-growth opportunity — $1.48B by 2033, compounding at 9.2%.
TAM · 2025$733Mtoday
TAM · 2033$1.48Bforecast
CAGR9.2%2027–2033
Cumulative$9.63Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.48BTotal addressable market
SAM$564MServiceable available market
SOM$94MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.2% CAGR
Demand compounds through 2033, outpacing GDP across Oxygenator Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Oxygenator Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.48BLarge & growingTAM by 2033 at 9.2% CAGR
$564MServiceable nowreachable with today’s model
$94MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.16BBear6.0% CAGR
$1.48BBase9.2% CAGR
$1.90BBull12.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
ECLS Oxygenator Market — a $3.38B market by 2033. Plan: grow share from 6.3% to 11.0%.
Market size · 2033$3.38Btotal addressable
Market CAGR11.3%2027–2033
Target share11.0%from 6.3% today
Revenue ambition$372Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.3% | 11.0% | On track |
| Revenue | $214M | $372M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.6% | 42.9% | Ahead |
| Customer retention | 86.7% | 94.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Oxygenator Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Oxygenator Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $52M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Oxygenator Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the ECLS Oxygenator Market conversation — a $5.73B market you can size, segment and defend in minutes.
Market size · 2033$5.73Btotal opportunity
Growth4.3%CAGR to 2033
Addressable buyers1,406+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Oxygenator Type
Goal Grow share in Oxygenator Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 2 mopayback period
$55K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
MedtronicLivaNovaTerumo CorporationGetinge (Maquet)Sorin Group (now part of LivaNova)Nipro CorporationSarns (part of Terumo)Xenios AG (a Fresenius Medical Care company)+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your ECLS Oxygenator Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
ECLS Oxygenator Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Eco Blanket Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportEco friendly straw Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportEco Funnel Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reporteCOA, eSource and Clinical Trials Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportEco-Composite Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportEco-Friendly Cement Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportEco-friendly Degreaser Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportEco-friendly Deodorizer Market
Market size, share, segmentation and regional forecast.
$799M market · 2025 base year
View reportEco-Friendly Diapers Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportEco-friendly Glue Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportEcofriendly Hydrocarbon Refrigerant Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportEco-Friendly Mining Equipment Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.